Read on Twitter
Thread
Hydroxychloroquine is shown to be effectiveness before the patient is sick enough to be admitted into the hospital.
What is only presented in the media are studies showing it does not work well. All of which are patients already sick enough to be admitted
Hydroxychloroquine is shown to be effectiveness before the patient is sick enough to be admitted into the hospital.
What is only presented in the media are studies showing it does not work well. All of which are patients already sick enough to be admitted
First ill start with thestatement from Association of American Physicians and Surgeons
"The HCQ-AZ combination, when started immediately after diagnosis, appears to be a safe and efficient treatment for COVID-19, with a mortality rate of 0.5%, in elderly patients.
"The HCQ-AZ combination, when started immediately after diagnosis, appears to be a safe and efficient treatment for COVID-19, with a mortality rate of 0.5%, in elderly patients.
It avoids worsening and clears virus persistence and contagious infectivity in most cases." https://aapsonline.org/hcq-90-percent-chance/
Study 1:
"Administration of the HCQ+AZ combination before COVID-19 complications occur is safe and associated with very low fatality rate in patients." https://www.sciencedirect.com/science/article/pii/S1477893920302179?via%3Dihub
"Administration of the HCQ+AZ combination before COVID-19 complications occur is safe and associated with very low fatality rate in patients." https://www.sciencedirect.com/science/article/pii/S1477893920302179?via%3Dihub
Study 2:
Of 166 patients from 18 to 85 years hospitalized with COVID-19, hydroxychloroquine treatment with 800mg added loading dose increased survival when patients were admitted in early stages of the disease. https://www.preprints.org/manuscript/202005.0057/v1
Of 166 patients from 18 to 85 years hospitalized with COVID-19, hydroxychloroquine treatment with 800mg added loading dose increased survival when patients were admitted in early stages of the disease. https://www.preprints.org/manuscript/202005.0057/v1
Study 3:
Hydroxychloroquine treatment is significantly associated with a decreased mortality in critically ill patients with COVID-19 through attenuation of inflammatory cytokine storm.
Hydroxychloroquine treatment is significantly associated with a decreased mortality in critically ill patients with COVID-19 through attenuation of inflammatory cytokine storm.
Therefore, hydroxychloroquine should be prescribed for treatment of critically ill COVID-19 patients to save lives. https://www.medrxiv.org/content/10.1101/2020.04.27.20073379v1
Study 4:
The present study suggests a potential interest of the combination therapy using HCQ/azithromycin for the treatment of COVID-19 in in-hospital patients https://www.medrxiv.org/content/10.1101/2020.05.05.20088757v1
The present study suggests a potential interest of the combination therapy using HCQ/azithromycin for the treatment of COVID-19 in in-hospital patients https://www.medrxiv.org/content/10.1101/2020.05.05.20088757v1
Study 5:
"zinc sulfate increased the frequency of patients being discharged home, and decreased the need for ventilation, admission to the ICU, and mortality or transfer to hospice for patients who were never admitted to the ICU"
https://www.medrxiv.org/content/10.1101/2020.05.02.20080036v1.full.pdf
"zinc sulfate increased the frequency of patients being discharged home, and decreased the need for ventilation, admission to the ICU, and mortality or transfer to hospice for patients who were never admitted to the ICU"
https://www.medrxiv.org/content/10.1101/2020.05.02.20080036v1.full.pdf
Study 6 (on safety):
200 Patients â no instances of TdP or arrhythmogenic death were reported
"Although use of these medications resulted in QT prolongation, clinicians seldomly needed to discontinue therapy."
https://www.ahajournals.org/doi/10.1161/CIRCEP.120.008662#.XrG-i8LBjDA.twitter
200 Patients â no instances of TdP or arrhythmogenic death were reported
"Although use of these medications resulted in QT prolongation, clinicians seldomly needed to discontinue therapy."
https://www.ahajournals.org/doi/10.1161/CIRCEP.120.008662#.XrG-i8LBjDA.twitter
Study 7 (on Prophylaxis)
"the in vivo 54 demonstration of prophylactic efficacy of HCQ could be a revolutionary result to prevent the transmission of 55 the virus, until the development of a vaccine"
https://www.jaad.org/article/S0190-9622(20)30757-X/pdf
"the in vivo 54 demonstration of prophylactic efficacy of HCQ could be a revolutionary result to prevent the transmission of 55 the virus, until the development of a vaccine"
https://www.jaad.org/article/S0190-9622(20)30757-X/pdf
Study 8 (on Prophylaxis)
"After a large COVID-19 exposure event in an LTCH in Korea, PEP using hydroxychloroquine (HCQ) was administered to 211 individuals, including 189 patients and 22 careworkers
"After a large COVID-19 exposure event in an LTCH in Korea, PEP using hydroxychloroquine (HCQ) was administered to 211 individuals, including 189 patients and 22 careworkers
At the end of 14 days of quarantine, all follow-up PCR tests were negative" https://www.sciencedirect.com/science/article/pii/S092485792030145X?via%3Dihub
Lets see what the rest of the world is doing regarding Hydroxychloroquine
Largest Statistically Significant Study by 6,200 Multi-Country Physicians on COVID-19 https://www.sermo.com/press-releases/largest-statistically-significant-study-by-6200-multi-country-physicians-on-covid-19-uncovers-treatment-patterns-and-puts-pandemic-in-context/
Largest Statistically Significant Study by 6,200 Multi-Country Physicians on COVID-19 https://www.sermo.com/press-releases/largest-statistically-significant-study-by-6200-multi-country-physicians-on-covid-19-uncovers-treatment-patterns-and-puts-pandemic-in-context/
Hydroxychloroquine usage amongst COVID-19 treaters is 72% in Spain, 49% in Italy, 41% in Brazil, 39% in Mexico, 28% in France, 23% in the U.S., 17% in Germany, 16% in Canada, 13% in the UK and 7% in Japan
Number Of Prescriptions Explodes In France
https://www.forbes.com/sites/alexledsom/2020/05/10/hydroxychloroquinenumber-of-prescriptions-explode-in-france/#597459b1180f
From Italy: 1039 patients treated with hydroxychloroquine at home. The point on experimentation: "Collapse of hospitalizations" https://www.ilfattoquotidiano.it/2020/04/28/coronavirus-da-nord-a-sud-1039-pazienti-trattati-a-casa-con-idrossiclorochina-il-punto-sulla-sperimentazione-crollo-dei-ricoveri/5783544/
https://www.forbes.com/sites/alexledsom/2020/05/10/hydroxychloroquinenumber-of-prescriptions-explode-in-france/#597459b1180f
From Italy: 1039 patients treated with hydroxychloroquine at home. The point on experimentation: "Collapse of hospitalizations" https://www.ilfattoquotidiano.it/2020/04/28/coronavirus-da-nord-a-sud-1039-pazienti-trattati-a-casa-con-idrossiclorochina-il-punto-sulla-sperimentazione-crollo-dei-ricoveri/5783544/
From Brazil:
"Doctor Marina Bucar Barjud, also from Floriano, treated more than 600 patients with the coronavirus in Madrid, where mortality from C ovid-19, from the same procedures, fell from 20% to 1.8% in the past few days."
https://cartapiaui.com.br/noticias/feitosa-costa/avanco-hospital-no-piaui-cura-pessoas-da-covid-19-e-esvazia-utis-com-uso-de-cloroquina-36954.html#.XrnGAgcPWbl.twitter\\
"Doctor Marina Bucar Barjud, also from Floriano, treated more than 600 patients with the coronavirus in Madrid, where mortality from C ovid-19, from the same procedures, fell from 20% to 1.8% in the past few days."
https://cartapiaui.com.br/noticias/feitosa-costa/avanco-hospital-no-piaui-cura-pessoas-da-covid-19-e-esvazia-utis-com-uso-de-cloroquina-36954.html#.XrnGAgcPWbl.twitter\\
